Alcohol Excipients Market Report 2026

The alcohol excipients market size has grown strongly in recent years. It will grow from $3.12 billion in 2025 to $3.41 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to rising pharmaceutical production, growing demand for oral and injectable drugs, advancements in formulation technologies, regulatory approvals for excipients, increasing R&D in drug delivery,.

The alcohol excipients market size is expected to see strong growth in the next few years. It will grow to $4.66 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to growing geriatric population, rise in personalized medicine, expansion of biologics and vaccines, adoption of novel excipient-based formulations, increasing pharmaceutical exports. Major trends in the forecast period include enhanced drug solubility and absorption, advanced formulation stability, controlled and regulated drug release, growing demand for inactive pharmaceutical ingredients, increasing focus on patient-centric drug delivery.

The rising use of medical drugs is anticipated to drive the growth of the alcohol excipients market in the coming years. As more individuals depend on prescription medications due to demographic shifts, expanded healthcare access, and the increasing medicalization of daily life, there is a growing demand for excipients that enhance drug delivery. Alcohol excipients aid in improving solubility, stability, and formulation acceptability, ensuring that medications are effective and user-friendly. For example, in June 2025, according to the NHS Business Services Authority (NHSBSA), a UK-based executive non-departmental public body, the number of prescription items dispensed in the community increased from 1.21 billion in 2023 to 1.26 billion in 2024, reflecting a 4% rise. Thus, the increasing consumption of medical drugs is fueling the growth of the alcohol excipients market.

The increasing prevalence of chronic diseases is expected to drive the growth of the alcohol excipients market in the coming years. Chronic diseases are long-term medical conditions such as diabetes, hypertension, and cardiovascular disorders that require ongoing treatment, continuous medication use, and regular clinical supervision. The rise in chronic disease prevalence is influenced by factors such as aging populations, lifestyle-related health risks, and growing rates of metabolic disorders. Alcohol excipients aid in managing chronic diseases by improving the solubility, stability, and absorption of long-term medications, ensuring more consistent therapeutic outcomes for patients managing ongoing health conditions. For example, in June 2024, according to the National Health Service, a UK-based government agency, 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, representing an 18% increase from 3,065,825 cases in 2022. Thus, the rising prevalence of chronic diseases is fueling the growth of the alcohol excipients market.

In July 2023, Croda International Plc, a UK-based specialty chemicals company, acquired Solus Biotech for an undisclosed amount. Through this acquisition, Croda aimed to enhance its biotechnology capabilities and expand its Beauty Actives and Pharma portfolio by obtaining access to high-growth, natural actives. Solus Biotech is a South Korea-based biotechnology company that focuses on providing various alcohol excipients, including myristyl alcohol, cetyl alcohol, and benzyl alcohol.

Major companies operating in the alcohol excipients market are Cargill Inc., Archer Daniels Midland Company, The Dow Chemical Company, Honeywell International Inc., Mitsubishi Chemical Holdings Corporation, Merck KGaA, Kerry Group plc, Lonza Group Ltd., The Lubrizol Corporation, Clariant AG, IMCD NV, Azelis Group NV, Roquette Frères SA, Croda International Plc, BASF SE, ABITEC Corporation, Duchefa Farma B.V., Signet Chemical Corporation Pvt. Ltd., Pharm Rx Chemical Corporation, HRV Global Life Sciences Private Limited.

Asia-Pacific was the largest region in the alcohol excipients market in 2025. The regions covered in the alcohol excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the alcohol excipients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have posed challenges to the alcohol excipients market by increasing the cost of raw alcohol materials and import duties, thereby affecting global supply chains and manufacturing costs. Pharmaceutical segments, particularly high-purity excipients for injectable and oral formulations, are most impacted, with regions such as North America, Europe, and Asia-Pacific experiencing supply disruptions. Some manufacturers may benefit from tariffs by localizing production and sourcing domestically, driving innovation in cost-efficient excipient solutions.

The alcohol excipients market research report is one of a series of new reports that provides alcohol excipients market statistics, including alcohol excipients industry global market size, regional shares, competitors with a alcohol excipients market share, detailed alcohol excipients market segments, market trends and opportunities, and any further data you may need to thrive in the alcohol excipients industry. This alcohol excipients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Alcohol excipients are pharmacologically inactive substances used alongside active pharmaceutical ingredients (APIs) to enhance drug formulation and delivery. They function as solvents or carriers, improving drug solubility, stability, and absorption. Alcohol excipients play a vital role in ensuring the efficacy and safety of pharmaceutical products by enabling controlled release and consistent bioavailability.

The main types of alcohol excipients include sorbitol, mannitol, propylene glycol, glycerin, and others. Sorbitol is a sugar alcohol commonly used in pharmaceuticals and personal care products. Its applications span pharmaceuticals, personal care, cosmetics, and other areas through various distribution channels such as direct tender, retail sales, and others.

The alcohol excipients market consists of sales of isopropyl alcohol, ethanol, and benzyl alcohol. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.